Agency information collection activities: Reporting and recordkeeping requirements,

Text

---

Federal Register: July 8, 1999 (Volume 64, Number 130)NoticesPage 36884-36885From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr08jy99-76

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Docket No. 98N-1110Agency Information Collection Activities; Announcement of OMB Approval; Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

SUMMARY: The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``CGMP Regulations for Finished Pharmaceuticals'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (the PRA).

FOR FURTHER INFORMATION CONTACT: Karen L. Nelson, Office of Information Resources Management (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1482.

SUPPLEMENTARY INFORMATION: In the Federal Register of April 19, 1999 (64 FR 19180), the agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0139. The approval expires on June 30, 2002. A copy of the supporting statement for this information collection is available on the Internet at ``http://www.fda.gov/ohrms/dockets''.

[Page 36885]

Dated: June 30, 1999. Margaret M. Dotzel, Acting Associate Commissioner for Policy Coordination.

FR Doc. 99-17332Filed7-7-99; 8:45 amBILLING CODE 4160-01-F

---